Argo Therapeutics
PrivateLast Round
Accelerator
Nov 10, 2020
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Argo Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was an Accelerator round in November 2020.
Argo Therapeutics is a biotechnology company that develops first-in-class therapies for neurodegenerative diseases such as ALS and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Argo Therapeutics Comparables
Compare Argo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Topos Bio | 86% | |
| Verge Genomics | 84% | |
| Brenig Therapeutics | 82% |
For institutional investors. Book with your work email.
Argo Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Argo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BaseLaunch | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 559% MoM, from 273 to 1.8K.
- Jun 20, 2026
Monthly visitors grew 237% MoM, reaching 273.
For institutional investors. Book with your work email.
Argo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Argo Therapeutics's valuation, stock price, and market status.
Is Argo Therapeutics a public or private company?
Argo Therapeutics is a private company.
What is the current stock price of Argo Therapeutics?
Argo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Argo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Argo Therapeutics worth (valuation)?
Valuation information for Argo Therapeutics is not publicly available.
Can I buy Argo Therapeutics stock?
Argo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Argo Therapeutics's last funding round?
Argo Therapeutics's most recent funding round was Accelerator on November 10, 2020.
Who are the main investors in Argo Therapeutics?
Key investors in Argo Therapeutics include BaseLaunch.
Will Argo Therapeutics IPO soon?
No public IPO plans have been announced for Argo Therapeutics.
How can I track Argo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Argo Therapeutics's shares on secondary markets.